Study Finds Half of RSV TikToks Are Health Pros

Researchers found that nearly half of TikTok videos on RSV immunization contained high-quality health information.

Updated on Nov. 20, 2026 in Children’s Health

Bold vector editorial illustration of stacked blank pastel cards beside a small glass vial on a cream surface, evoking evaluation of online vaccine information.
Researchers at Rutgers New Jersey Medical School found 47% of 169 TikTok videos about RSV immunization presented high-quality health information. AI Illustration. Upload story photo >

Live Poll

Do you trust health information you find on TikTok?

Researchers from Rutgers New Jersey Medical School analyzed 169 TikTok videos about RSV immunization posted between July 2023 and November 2025, published in Vaccine. Forty-seven percent of the videos presented high-quality information, while about 20% were mixed or uncertain and 3% contained misinformation.

Why it matters

Parents often turn to social media for information about infant vaccines, and the quality of that content varies widely. The findings highlight the need for clinicians to guide families toward evidence-based resources after encountering online material.

Of 169 RSV immunization TikToks analyzed, 79 were rated high-quality on the five-point Global Quality Scale, with a median score of three. The study does not measure how these videos affected viewers' vaccination decisions.

The players

Rutgers New Jersey Medical School

A medical school in New Jersey affiliated with Rutgers University, whose researchers conducted the analysis.

The details

Researchers searched TikTok for terms such as RSV vaccine, RSV jab, and RSV prophylaxis and evaluated the health information in the resulting videos. Healthcare professionals created 50.3% of the videos, parents and caregivers 37.9%, and influencers 4.7%.

Timeline

  1. July 17, 2023: Earliest analyzed RSV immunization TikTok video was posted.

  2. November 14, 2025: Latest analyzed RSV immunization TikTok video was posted.

  3. The videos were posted following the U.S. Food and Drug Administration's approval of nirsevimab.

Big Picture

The study examines social media discussion that followed the U.S. Food and Drug Administration's approval of nirsevimab, the infant RSV immunization. It shows that public understanding of newly approved pediatric vaccines is shaped heavily by short-form video content of uneven quality.

Parents researching RSV immunization for their infants may encounter videos of mixed quality, so checking claims against clinician-reviewed sources is advisable. Discussing the immunization with a pediatrician before deciding can help families separate accurate information from misinformation.

The takeaway

Health information on social media varies in accuracy, and viewers should verify RSV vaccine claims with their child's healthcare provider. Clinicians are encouraged to direct families to evidence-based resources when they bring online information to appointments.

Further reading

Explore more on Children's Health for guidance on infant vaccines and the information families encounter online.

Live Poll

Do you trust health information you find on TikTok?